BENZTROPINE OMEGA 1 MG
BENZTROPINE MESYLATE : 1 MG · DIN 02238903 · OMEGA LABORATORIES LIMITED
Health Canada status: MARKETED
What is BENZTROPINE OMEGA?
BENZTROPINE OMEGA 1 MG contains BENZTROPINE MESYLATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02238903, held by OMEGA LABORATORIES LIMITED, supplied as LIQUID for INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 23-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is BENZTROPINE OMEGA called?
Also recorded in Canada as: 2 ML benztropine mesylate 1 MG/ML Injection (US), benztropine mesylate 2 MG Oral Tablet (US), benztropine mesylate 1 MG Oral Tablet (US), benztropine mesylate 0.5 MG Oral Tablet (US), BENZTROPINE MESYLATE (US).
The same molecule, BENZATROPINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Benzatropine Injection | Latin | Australia |
| Benztrop | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02238903 |
|---|---|
| Brand name | BENZTROPINE OMEGA |
| Generic / active ingredient | BENZTROPINE MESYLATE : 1 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 1 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N04AC01 BENZATROPINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Jul-1999 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02238903 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2238903 |
| Brand name | BENZTROPINE OMEGA |
| Active ingredient / INN | BENZTROPINE MESYLATE : 1 MG |
| ATC code | N04AC01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N04 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | OMEGA LABORATORIES LIMITED |
Which pack is which?
| Strength on the label | 1 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAVENOUS ; INTRAMUSCULAR |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N04AC01 BENZATROPINE. 2 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PDP-BENZTROPINE | 1 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00706531 |
| BENSYLATE TAB 2MG | 2 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00428086 |
| BENZTROPINE | 2 MG / 2 ML | SOLUTION | PHEBRA PTY LTD | DORMANT | DIN 02486822 |
| BENZTROPINE 2 TAB 2MG | 2 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563862 |
| BENZTROPINE MESYLATE INJECTION, USP | 1 MG | LIQUID | SABEX INC | CANCELLED PRE MARKET | DIN 02243121 |
| COGENTIN INJ 1MG/ML | 1 MG | SOLUTION | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016128 |
| COGENTIN TAB 2MG | 2 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00016357 |
| DOM-BENZTROPINE | 2 MG | TABLET | DOMINION PHARMACAL | CANCELLED PRE MARKET | DIN 02241791 |
| PDP-BENZTROPINE | 2 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT | DIN 00426857 |
| PDP-BENZTROPINE | 2 MG / 5 ML | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02219727 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.